Optimising the body's immune response with a Nanopatch that delivers biomolecules to the skin

通过向皮肤输送生物分子的纳米贴片优化身体的免疫反应

• 批准号: FT0991982
• 负责人: Prof Mark Kendall
• 金额: $ 63.57万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: ARC Future Fellowships
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-03-31 至 2014-03-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/FT0991982
• 关键词: Optimising; body; immune; response; Nanopatch

The team is developing a new improved way to vaccinate against deadly infectious diseases such as influenza and malaria. They believe their Nanopatch technology will boost the power of seasonal influenza vaccination and could even solve vaccine shortages in an influenza pandemic. This is because the Nanopatch needs much less vaccine per person than a conventional syringe. They also predict that vaccines delivered with a Nanopatch will require less refrigeration than conventional vaccines and can be safely administered by individuals without medical training, making the benefits of vaccination accessible to more people more cheaply, even in remote areas.

该团队正在开发一种新的改进方法来接种流感和疟疾等致命传染病的疫苗。他们相信，他们的Nanopatch技术将增强季节性流感疫苗接种的力量，甚至可以解决流感大流行中的疫苗短缺问题。这是因为Nanopatch每人需要的疫苗比传统注射器少得多。他们还预测，与传统疫苗相比，使用纳米贴片交付的疫苗需要的冷藏时间更少，而且无需医疗培训就可以安全地由个人接种，从而使更多人能够以更低的成本获得疫苗接种的好处，即使是在偏远地区。